Clinical Trials Logo

Amantadine clinical trials

View clinical trials related to Amantadine.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT06443827 Active, not recruiting - Clinical trials for Electroencephalography

Effect of Intravenous Amantadine Sulphate on Disorders of Consciousness

DOC-AMSUL
Start date: September 15, 2018
Phase: Phase 2
Study type: Interventional

Double-blind, placebo-controlled, crossover ("within subjects") study with an A-B-A-B treatment scheme to investigate the neuromodulatory effects of intravenous amantadine sulphate at a single daily dose of 200 mg in patients with disorders of consciousness (unresponsive wakefulness syndrome and minimally conscious state) by integrating traditional neurobehavioral assessment with spectral analysis of electrocortical activity derived from 64-channel electroencephalography (EEG) recordings.